Get the Stockscreener App
11.20
2.28%
0.25
After Hours:
11.02
-0.18
-1.61%
Transcode Therapeutics Inc stock is traded at $11.20, with a volume of 15,452.
It is up +2.28% in the last 24 hours and up +4.19% over the past month.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
See More
Previous Close:
$10.95
Open:
$11.33
24h Volume:
15,452
Relative Volume:
0.11
Market Cap:
$9.34M
Revenue:
-
Net Income/Loss:
$-14.93M
P/E Ratio:
-0.0421
EPS:
-266.137
Net Cash Flow:
$-15.87M
1W Performance:
-16.36%
1M Performance:
+4.19%
6M Performance:
-1.62%
1Y Performance:
-97.39%
1-Day Range:
$10.98
$11.33
1-Week Range:
$10.90
$13.96
52-Week Range:
$6.1478
$504.97
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Name
Transcode Therapeutics Inc
Sector
Industry
Phone
857-301-6857
Address
6 LIBERTY SQUARE, BOSTON
Compare RNAZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
11.20 | 10.04M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Transcode Therapeutics Inc Stock (RNAZ) Latest News
How to manage a losing position in TransCode Therapeutics Inc.Market Movers & Growth Focused Stock Pick Reports - newser.com
Why TransCode Therapeutics Inc. stock could be next big winnerGap Up & Consistent Profit Focused Trading Strategies - newser.com
TransCode Therapeutics Inc. recovery potential after sell offPortfolio Performance Summary & Fast Entry High Yield Tips - newser.com
Is TransCode Therapeutics Inc. stock oversold or undervaluedWeekly Trade Recap & Intraday High Probability Alerts - newser.com
Is TransCode Therapeutics Inc. stock attractive for growth ETFs2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com
Why retail investors favor TransCode Therapeutics Inc. stock2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
Market reaction to TransCode Therapeutics Inc.’s recent newsWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
What to do if you’re stuck in TransCode Therapeutics Inc.2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
What technical models suggest about TransCode Therapeutics Inc.’s comebackJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
How TransCode Therapeutics Inc. stock reacts to job market dataTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
What MACD and RSI say about TransCode Therapeutics Inc.2025 Top Gainers & Consistent Profit Alerts - newser.com
Using Python tools to backtest TransCode Therapeutics Inc. strategiesWeekly Market Summary & Weekly High Return Opportunities - newser.com
What’s the recovery path for long term holders of TransCode Therapeutics Inc.Market Trend Review & Stepwise Trade Signal Implementation - newser.com
Is a relief rally coming for TransCode Therapeutics Inc. holdersWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Forecasting TransCode Therapeutics Inc. price range with options dataEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Can TransCode Therapeutics Inc. stock weather global recessionJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com
Using Bollinger Bands to evaluate TransCode Therapeutics Inc.Weekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Why TransCode Therapeutics Inc. stock is considered a top pickJuly 2025 Selloffs & Verified High Yield Trade Plans - newser.com
Transcode Therapeutics amends preferred stock terms following shareholder approval By Investing.com - Investing.com Nigeria
Why TransCode Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Volume & Low Risk High Reward Ideas - Fundação Cultural do Pará
TransCode Therapeutics Amends Preferred Stock Designation - TipRanks
Transcode Therapeutics amends preferred stock terms following shareholder approval - Investing.com
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):